New Age Alpha Advisors, LLC Biocryst Pharmaceuticals Inc Transaction History
New Age Alpha Advisors, LLC
- $2.27 Trillion
- Q2 2025
A detailed history of New Age Alpha Advisors, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, New Age Alpha Advisors, LLC holds 8,511 shares of BCRX stock, worth $59,832. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,511
Previous 8,235
3.35%
Holding current value
$59,832
Previous $61.8 Million
23.47%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BCRX
# of Institutions
317Shares Held
201MCall Options Held
930KPut Options Held
553K-
Vanguard Group Inc Valley Forge, PA21.8MShares$153 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$140 Million0.0% of portfolio
-
State Street Corp Boston, MA8.51MShares$59.8 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.46MShares$59.5 Million9.06% of portfolio
-
Alkeon Capital Management LLC New York, NY5.71MShares$40.2 Million0.09% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.31B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...